# Triple Site Ventricular Stimulation for Cardiac Resynchronization Therapy (CRT) Candidates

> **NCT00887237** · PHASE3 · COMPLETED · sponsor: **Medtronic Cardiac Rhythm and Heart Failure** · enrollment: 76 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DEVICE:** CRT with triple site ventricular stimulation
- **DEVICE:** Conventional cardiac resynchronization

## Key facts

- **NCT ID:** NCT00887237
- **Lead sponsor:** Medtronic Cardiac Rhythm and Heart Failure
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2013-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00887237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00887237, "Triple Site Ventricular Stimulation for Cardiac Resynchronization Therapy (CRT) Candidates". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00887237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*